Showing 1 - 7 results of 7 for search 'David S Siegel', query time: 0.02s
Refine Results
-
1
-
2
-
3
-
4
-
5
Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma by Lawrence G Lum, Parameswaran Hari, Aniko Szabo, Michele Donato, Jee Hyun Park, Daniel H Fowler, Binod Dhakal, Saurabh Chhabra, Deborah D Glass, David S Siegel, Tania C Felizardo
Published 2025-01-01Get full text
Article -
6
A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma by Noa Biran, Eli Zolotov, David Vesole, Harsh Parmar, Pooja Phull, Kimberley Doucette, Patrick Roney, Jaeil Ahn, Rena Feinman, Joshua Zenreich, Palka Anand, Monique Pace, Alexandra Della Pia, Bianca DeAgresta, Lisa Biamonte, Adolfo Aleman, Ella Rutanen, Aimee Chappell, Susan Kumka, David S. Siegel
Published 2025-04-01Get full text
Article -
7
Restoring sensitivity to daratumumab with all-transretinoic acid in a patient with daratumumab-refractory multiple myeloma: A case report and review of the literature by Noa Biran, David H. Vesole, Harsh Parmar, Pooja Phull, Susan Kumka, Kimberley Doucette, Joshua Zenreich, Bianca DeAgresta, Alexandra Della Pia, Lisa Biamonte, Martha Campanaro, Trina McClendon, Samanta BaboolallAracena, Palka Anand, Adolfo Aleman, Monique Pace, Genevieve Breeze, Kristin Ivanovski, Marie Layton, David S. Siegel
Published 2025-03-01Get full text
Article